Merck (NYSE:MRK) Expands Life Sciences With Strategic Biotech Acquisition

Merck (NYSE:MRK) Expands Life Sciences With Strategic Biotech Acquisition  Kalkine Media

Summary aggregated from Kalkine Media's public RSS feed. The full reporting belongs to Kalkine Media — please read it on their site.